-
1
-
-
0003536740
-
-
Washington, DC: Office of Disease Prevention and Health Promotion
-
U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Washington, DC: Office of Disease Prevention and Health Promotion; 1996.
-
(1996)
Guide to Clinical Preventive Services. 2nd Ed.
-
-
-
3
-
-
0003964363
-
-
American Cancer Society. Cancer Facts & Figures 2003. Available at: http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Accessed April 2, 2003.
-
Cancer Facts & Figures 2003
-
-
-
4
-
-
0026760830
-
Should women with familial, ovarian cancer undergo prophylactic oophorectomy?
-
Kerlikowske K, Brown JS, Grady DG. Should women with familial, ovarian cancer undergo prophylactic oophorectomy? Obstet Gynecol. 1992;80:700-707.
-
(1992)
Obstet Gynecol
, vol.80
, pp. 700-707
-
-
Kerlikowske, K.1
Brown, J.S.2
Grady, D.G.3
-
5
-
-
0028798979
-
The genetics of breast and ovarian cancer
-
Ford D, Easton DF. The genetics of breast and ovarian cancer. Br J Cancer. 1995;72:805-812.
-
(1995)
Br J Cancer
, vol.72
, pp. 805-812
-
-
Ford, D.1
Easton, D.F.2
-
6
-
-
0027092659
-
Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women
-
Collaborative Ovarian Cancer Group
-
Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol. 1992;136:1184-1203.
-
(1992)
Am J Epidemiol
, vol.136
, pp. 1184-1203
-
-
Whittemore, A.S.1
Harris, R.2
Itnyre, J.3
-
7
-
-
0037125454
-
Menopausal hormone replacement therapy and risk of ovarian cancer
-
Lacey JV Jr, Mink PJ, Lubin JH, et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA. 2002;288:334-341.
-
(2002)
JAMA
, vol.288
, pp. 334-341
-
-
Lacey Jr., J.V.1
Mink, P.J.2
Lubin, J.H.3
-
8
-
-
0035925788
-
Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women
-
Rodriguez C, Patel A, Calle E, Jacob E, Thun M. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA. 2001;285:1460-1465.
-
(2001)
JAMA
, vol.285
, pp. 1460-1465
-
-
Rodriguez, C.1
Patel, A.2
Calle, E.3
Jacob, E.4
Thun, M.5
-
9
-
-
0033541548
-
Screening for ovarian cancer: A pilot randomised controlled trial
-
Jacobs IJ, Skates SJ, MacDonald N, et al. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet. 1999;353:1207-1210.
-
(1999)
Lancet
, vol.353
, pp. 1207-1210
-
-
Jacobs, I.J.1
Skates, S.J.2
MacDonald, N.3
-
10
-
-
0034255489
-
Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography
-
Sato S, Yokoyama Y, Sakamoto T, Futagami M, Saito Y. Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography. Cancer. 2000;89:582-588.
-
(2000)
Cancer
, vol.89
, pp. 582-588
-
-
Sato, S.1
Yokoyama, Y.2
Sakamoto, T.3
Futagami, M.4
Saito, Y.5
-
11
-
-
0034044453
-
The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer
-
van Nagell JR Jr, DePriest PD, Reedy MB, et al. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol. 2000;77:350-356.
-
(2000)
Gynecol Oncol
, vol.77
, pp. 350-356
-
-
Van Nagell Jr., J.R.1
DePriest, P.D.2
Reedy, M.B.3
-
12
-
-
0023911286
-
Multimodal approach to screening for ovarian cancer
-
Jacobs I, Stabile I, Bridges J, et al. Multimodal approach to screening for ovarian cancer. Lancet. 1988;1:268-271.
-
(1988)
Lancet
, vol.1
, pp. 268-271
-
-
Jacobs, I.1
Stabile, I.2
Bridges, J.3
-
13
-
-
0027405117
-
Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography
-
Jacobs I, Davies AP, Bridges J, et al. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. BMJ. 1993;306:1030-1034.
-
(1993)
BMJ
, vol.306
, pp. 1030-1034
-
-
Jacobs, I.1
Davies, A.P.2
Bridges, J.3
-
14
-
-
0029881226
-
A combined approach for the early detection of ovarian cancer in asymptomatic women
-
Adonakis GL, Paraskevaidis E, Tsiga S, Seferiadis K, Lolis DE. A combined approach for the early detection of ovarian cancer in asymptomatic women. Eur J Obstet Gynecol Reprod Biol. 1996;65:221-225.
-
(1996)
Eur J Obstet Gynecol Reprod Biol
, vol.65
, pp. 221-225
-
-
Adonakis, G.L.1
Paraskevaidis, E.2
Tsiga, S.3
Seferiadis, K.4
Lolis, D.E.5
-
15
-
-
0002210657
-
Screening for ovarian cancer: A systematic review
-
Bell R, Petticrew M, Luengo S, Sheldon TA. Screening for ovarian cancer: a systematic review. Health Technol Assess. 1998;2(2):i-iv, 1-84.
-
(1998)
Health Technol Assess
, vol.2
, Issue.2
-
-
Bell, R.1
Petticrew, M.2
Luengo, S.3
Sheldon, T.A.4
-
16
-
-
0029089042
-
Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound
-
Vuento MH, Pirhonen JP, Makinen JI, Laippala PJ, Gronroos M, Salmi TA. Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound. Cancer. 1995;76:1214-1218.
-
(1995)
Cancer
, vol.76
, pp. 1214-1218
-
-
Vuento, M.H.1
Pirhonen, J.P.2
Makinen, J.I.3
Laippala, P.J.4
Gronroos, M.5
Salmi, T.A.6
-
17
-
-
0028000165
-
An attempt to screen asymptomatic women for ovarian and endometrial cancer with transvaginal color and pulsed Doppler sonography
-
Kurjak A, Shalan H, Kupesic S, et al. An attempt to screen asymptomatic women for ovarian and endometrial cancer with transvaginal color and pulsed Doppler sonography. J Ultrasound Med. 1994;13:295-301.
-
(1994)
J Ultrasound Med
, vol.13
, pp. 295-301
-
-
Kurjak, A.1
Shalan, H.2
Kupesic, S.3
-
18
-
-
0034572611
-
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status
-
Gohagan JK, Prorok PC, Hayes RB, Kramer BS. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials. 2000;21 (6 Suppl):251S-272S.
-
(2000)
Control Clin Trials
, vol.21
, Issue.6 SUPPL.
-
-
Gohagan, J.K.1
Prorok, P.C.2
Hayes, R.B.3
Kramer, B.S.4
-
19
-
-
18044402499
-
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
-
Prorok PC, Andriole GL, Bresalier RS, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21 (6 Suppl):273S-309S.
-
(2000)
Control Clin Trials
, vol.21
, Issue.6 SUPPL.
-
-
Prorok, P.C.1
Andriole, G.L.2
Bresalier, R.S.3
-
21
-
-
73249121979
-
-
American Cancer Society. Can ovarian cancer be found early? Available at: http://www.cancer.org/docroot/CRI/content/ CRI_2_4_3X_Can_ovarian_cancer_be_found_early_33.asp?sitearea. Accessed April 2, 2003.
-
Can Ovarian Cancer be Found Early?
-
-
-
22
-
-
0036884190
-
The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer
-
Committee Opinion No: 280
-
American College of Obstetricians and Gynecologists. Committee Opinion No: 280. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. Gynecol Oncol. 2002;87:237-239.
-
(2002)
Gynecol Oncol
, vol.87
, pp. 237-239
-
-
-
23
-
-
0242307659
-
Screening for ovarian cancer
-
Canadian Task Force on the Periodic Health Examination. Ottawa: Health Canada
-
Gladstone CQ. Screening for ovarian cancer. In: Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada, 1994;870-881.
-
(1994)
Canadian Guide to Clinical Preventive Health Care
, pp. 870-881
-
-
Gladstone, C.Q.1
|